Welcome to our dedicated page for Envista Holdings news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings stock.
Envista Holdings Corporation (NYSE: NVST) is a dental products company that regularly issues news about its operations, financial performance, and participation in industry events. Company press releases describe Envista as a global family of more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, focused on partnering with professionals to improve patients’ lives through dental consumables, equipment, technology, and services.
The NVST news feed features updates on quarterly results, earnings guidance, and operational priorities such as growth, operations, and people. Envista frequently announces its quarterly earnings through press releases and associated conference calls, providing details on sales, margins, and business highlights for its Specialty Products & Technologies and Equipment & Consumables segments. These releases often discuss performance across major businesses and geographies, as well as progress in areas like margin improvement and customer service levels.
Investors and observers can also find news about Envista’s participation in healthcare and investor conferences, where the company presents its strategy and outlook. Announcements have included presentations at events such as the J.P. Morgan Healthcare Conference, the Evercore Healthcare Conference, and other sector-focused meetings, typically accompanied by webcasts available through the company’s investor relations site.
In addition, Envista issues news on topics such as strategic partnerships and sustainability. For example, a press release highlighted a multi-year IT managed services partnership with Hitachi Digital Services to support operations in more than 60 countries. Another 8-K filing references the release of a Sustainability Report covering environmental, social, and governance topics. For those tracking NVST, this news stream provides insight into financial trends, strategic initiatives as described by the company, and developments across its global dental brands.
Envista Holdings Corporation (NYSE: NVST) will release its first quarter 2022 financial results on May 4, 2022. A conference call to discuss these results is scheduled for 2:00 PM PT on the same day, lasting approximately one hour. The call will be accessible via phone or through a webcast on the company's website. Materials related to the earnings will be available on the Investors section of Envista's site prior to the call and afterward. Envista is a leading global dental products company with a focus on improving patient care through innovative solutions.
Envista Holdings Corporation (NYSE: NVST) has announced the rebranding of its KaVo imaging business to DEXIS. Known for over 20 years as a leader in digital intraoral radiography, the DEXIS brand will now encompass a comprehensive portfolio, including cone-beam computed tomography (CBCT), handheld x-rays, and intraoral scanners. The DEXIS brand, integrating various leading brands, aims to enhance digital workflows for dental professionals. The transition to DEXIS branding will occur throughout 2022, affecting different products and regions.
Envista Holdings Corporation (NYSE: NVST) announced FDA clearance for its Assisted Intelligence (AI) mandibular nerve tracing feature in the DTX Studio Clinic software. This advancement is crucial for preventing complications in dental procedures by improving visualization. The DTX platform previously received clearances for various AI functionalities, enhancing efficiency for clinicians. CEO Amir Aghdaei highlighted this as a significant step in expanding their digital strategy, aiming to reduce clinician workload while increasing patient focus. Envista continues to innovate in the dental industry with its comprehensive portfolio.
Envista Holdings Corporation (NYSE: NVST) announced its participation in Piper Sandler Dental Day scheduled for March 29, 2022, from 7:00 – 7:45 AM PT. Investors can access recordings of the event via Envista's Investor Relations website under Events and Presentations.
As one of the largest global dental products companies, Envista operates over 30 renowned dental brands, focusing on enhancing patient care through a comprehensive portfolio that includes dental implants, orthodontics, and advanced imaging technologies.
Envista Holdings Corporation (NYSE: NVST) will host its inaugural Investor Day at the Envista Summit on April 1, 2022, from 8:00 am to 10:30 am CT. The hybrid event aims to enhance customer engagement by showcasing Envista's differentiated product portfolio and digital solutions. Attendees can register online, with options for virtual participation or limited in-person attendance. The Envista Summit combines the Ormco Forum and Nobel Biocare Symposium, introducing a new 'Technology Track' to cover various clinical workflows.
Envista Holdings Corporation (NYSE: NVST) will participate in the Jefferies Virtual Dental Summit on February 24, 2022, from 6:00 – 6:45 AM PST. Investors can access recordings on the company's Investor Relations website under Events and Presentations. Envista is a global leader in dental products, offering a comprehensive portfolio that covers approximately 90% of dentists' clinical needs. The company emphasizes continuous improvement, innovation, and customer focus to enhance patient care and strengthen its market position.
Summary not available.
Envista Holdings Corporation (NYSE: NVST) reported a strong fourth quarter and full year 2021, following the divestiture of its KaVo Treatment Unit. Sales increased 5.8% to $651.8 million, with a core sales growth of 6.6% year-over-year. Full year core sales growth reached 29%. Fourth quarter net income was $42.5 million, with adjusted net income at $81.1 million, a 12% increase from the prior year. Looking ahead, Envista expects 2022 core growth of 6-8% and an adjusted EBITDA margin exceeding 20%, while indicating future guidance will be updated after the anticipated acquisition of Carestream Dental's IOS business.
Envista Holdings Corporation (NYSE: NVST) has renewed its partnership with the Vitaldent Group, a prominent Spanish Dental Service Organization. This agreement positions Envista as the preferred supplier for dental implants (Nobel Biocare) and clear aligners (Spark) for the next three years. Vitaldent, which has collaborated with Nobel Biocare since 2009, emphasizes the importance of innovative technology in providing quality dental care. The partnership aims to enhance clinical outcomes and patient satisfaction using advanced dental treatments.
Envista Holdings Corporation (NYSE: NVST) recently announced a five-year extension and expansion of its commercial relationship with Pacific Dental Services (PDS). This partnership will now include Envista's Spark clear aligners in addition to existing implant and imaging services. The collaboration aims to enhance implant treatment capabilities and improve diagnostic accuracy through advanced 3D imaging technology. Envista's SVP highlighted the commitment to clinical excellence, while PDS’s COO praised the partnership for enhancing patient care across over 850 supported practices.